skip to Main Content

Cover image of TAG Policy Brief: Hepatitis C and COVID-19 Global Concerns Cover of November 2020 TAGline: 'The Struggle of a Lifetime' (Continued) Homepage slider image of cover of Tuberculosis Research Funding Trends, 2005-2019
Image montage of TAG Limited Art Editions
Image link to About the COVID-19 Project page
Research in Action Awards 2020 - watch the video now!

Pipeline Reports

The current ones are all online and available for download now.




February 18, 2021
Nitrosamines and TB Medicines Information Note and Patient FAQs
In 2020, health authorities and drug manufacturers identified a type of chemical impurity called nitrosamines in rifampicin and rifapentine, two essential medicines used in the treatment and prevention of TB. TAG has developed several materials to help people affected by TB, advocates, policymakers, and implementers understand how the identification of…

February 18, 2021
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).

February 17, 2021
Pre- and Post-CROI Community HIV Cure Research Workshop
Webinar / Presentation
The 2021 Community HIV Cure Research Workshop will take place virtually this year due to the ongoing COVID-19 pandemic. The workshop sessions will be held on Thursday, March 4 and Friday, March 5, 2021 (right before CROI 2021), and then on Tuesday, March 16, 2021 (after the conference).

February 16, 2021
Community Movements Across Africa, Asia and South America Celebrate Roll-Out of Short-Course, Patient-Friendly TB Preventive Therapy
Statement / Press
Advocates and affected communities working towards the global scale-up of short-course TB preventive therapy (TPT) hail the recent announcement of the launch of decently priced, patient-friendly fixed-dose combinations (FDC) of 3HP in five high burden HIV and TB countries.

February 3, 2021
Harnessing the COVID-19 Response Towards Hepatitis C Elimination
Webinar / Presentation
On February 3, 2021, TAG, Médecins du Monde, hepCoalition, and the UNITE network presented a virtual policy dialogue among policymakers, global civil society organizations, and community leaders who share how COVID-19 has impacted global hepatitis C virus (HCV) elimination efforts.

Back To Top